Sanigen Co

Sanigen Co Current Assets

The Current Assets of Sanigen Co (188260.KQ) as of Oct 20, 2026 is 1.81 B KRW. In the previous year, Current Assets was 11.52 B KRW — a change of -84.30% (lower).

Current Assets

1.81 BKRW

YoY

-84.30%

Last updated:

Current Assets of Sanigen Co is 2025 1.81 B KRW. Current Assets of Sanigen Co was 2024 11.52 B KRW. It decreases by -84.30% lower compared to the previous year.

The Sanigen Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
6.82 B KRW
Jan 1, 2020
6.34 B KRW
Jan 1, 2021
5.41 B KRW
Jan 1, 2022
9.84 B KRW
Jan 1, 2023
16.17 B KRW
Jan 1, 2024
11.52 B KRW
Jan 1, 2025
1.81 B KRW
The Sanigen Co Current Assets history
YEARCurrent AssetsYoY
1.81 BKRW-84.30%
11.52 BKRW-28.75%
16.17 BKRW+64.25%
9.84 BKRW+81.77%
5.41 BKRW-14.56%
6.34 BKRW-7.10%
6.82 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sanigen Co Stock analysis

What does Sanigen Co do? Sanigen Co Ltd generates revenue through the manufacturing and sale of food safety diagnostic products, utilizing advanced molecular diagnostic technologies including polymerase chain reaction (PCR) and next-generation sequencing (NGS). The company provides food microbial genome analysis services as part of its offerings. Its primary customers are entities requiring food safety testing, such as food manufacturers and regulatory agencies. The firm operates within the Health Care Equipment & Supplies industry, focusing on diagnostic solutions for food safety. Sanigen Co Ltd's product portfolio includes diagnostic products developed using PCR and NGS technologies, which are sold to clients in the food safety sector. The company's services encompass microbial genome analysis, targeting clients needing detailed food safety assessments. The business model centers on delivering diagnostic tools and services that ensure food safety through advanced molecular technologies. The company's revenue streams are derived from the sale of diagnostic products and the provision of microbial genome analysis services. These offerings are tailored to meet the needs of food safety testing in the industry. Sanigen Co Ltd's focus on molecular diagnostic technologies positions it as a provider of specialized solutions within the health care equipment and supplies market. Sanigen Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sanigen Co stock

Current Assets of Sanigen Co is 1.81 B KRW in 2025.

Current Assets of Sanigen Co changed from 11.52 B KRW to 1.81 B KRW, representing a -84.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Sanigen Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Sanigen Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sanigen Co

All Key Metrics — Sanigen Co